Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both.The research service features daily updates of the Zacks Rank and Zacks Industry Rank, full access to the Zacks #1 Rank List, Equity Research reports, and Premium stock screens, all of which will help you become a smarter, more confident investor.It also includes access to the Zacks Style Scores.What are the Zacks Style Scores?The Zacks S ...

It has been about a month since the last earnings report for Amedisys (AMED) . Shares have added about 5.5% in that time frame, outperforming the S&P 500.Will the recent positive trend continue leading up to its next earnings release, or is Amedisys due for a pullback? Before we dive into how investors and analysts have reacted as of late, let's take a quick look at the most recent earnings report in order to get a better handle on the important catalysts. Amedisys Q4 Earnings Miss Estimates, Margins RiseAm ...

Core Insights - Amedisys, Inc. reported adjusted EPS of $1.03 for Q1 2024, a 3% increase from $1.00 in the same quarter last year, and beat the Zacks Consensus Estimate by 1.9% [1] - Net service revenues reached $571.4 million, reflecting a year-over-year growth of 2.7% and surpassing the Zacks Consensus Estimate by 1.2% [1] Segment Performance - Home Health division generated net service revenues of $364 million, up 6% year over year, with Medicare revenues at $215.8 million (up 0.2%) and non-Medicare revenues at $148.2 million (up 15.9%) [2] - Hospice division reported net service revenues of $201 million, a 3.9% increase year over year, with Medicare revenues at $190 million (up 4%) and non-Medicare revenues at $11 million (up 2.8%) [2] - High Acuity Care segment saw net service revenues of $6.4 million, a significant increase of 36.2% from the previous year [3] Financial Metrics - Gross profit improved by 3.5% to $249.9 million, with gross margin expanding by 35 basis points to 43.7% [4] - Adjusted operating profit rose by 25.9% to $64 million, with adjusted operating margin increasing by 207 basis points to 11.2% [4] Liquidity and Cash Position - Amedisys ended Q1 2024 with cash and cash equivalents of $108.2 million, down from $126.5 million at the end of 2023 [5] - Long-term obligations were $356.1 million at the end of Q1 2024, a slight decrease from $361.9 million at the end of 2023 [5] - Cumulative net cash used by operating activities was $6.5 million, compared to a cash inflow of $26 million a year ago [5] Strategic Outlook - The company is positioned for growth with an impending merger with UnitedHealth Group's Optum, aimed at enhancing value-based care [6] - Despite the positive earnings and revenue results, challenges include wage increases, wage inflation, and shifts in the home health payor mix [6]

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading Symbol(s) Name of each exchange on which registered Common Stock, par value $0.001 per share AMED The NASDAQ Global Select Market FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2024 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECU ...

Amedisys (AMED) reported $571.41 million in revenue for the quarter ended March 2024, representing a year-over-year increase of 2.7%. EPS of $1.03 for the same period compares to $1.00 a year ago.The reported revenue compares to the Zacks Consensus Estimate of $564.58 million, representing a surprise of +1.21%. The company delivered an EPS surprise of +1.98%, with the consensus EPS estimate being $1.01.While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Stre ...

Amedisys (AMED) came out with quarterly earnings of $1.03 per share, beating the Zacks Consensus Estimate of $1.01 per share. This compares to earnings of $1 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 1.98%. A quarter ago, it was expected that this home health care and hospice services provider would post earnings of $1.04 per share when it actually produced earnings of $0.94, delivering a surprise of -9.62%.Over the last ...

BATON ROUGE, La., April 24, 2024 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ:AMED) today reported its financial results for the three-month period ended March 31, 2024. Three-Month Periods Ended March 31, 2024 and 2023 Net service revenue increased $15.0 million to $571.4 million compared to $556.4 million in 2023. Prior year included $15.0 million of net service revenue from our personal care business which was divested on March 31, 2023.Net income attributable to Amedisys, Inc. of $14.4 million, which is ...

Exhibit 99.1 AMEDISYS REPORTS FIRST QUARTER 2024 FINANCIAL RESULTS BATON ROUGE, Louisiana (April 24, 2024) — Amedisys, Inc. (NASDAQ: AMED) today reported its financial results for the threemonth period ended March 31, 2024. Three-Month Periods Ended March 31, 2024 and 2023 ◦ Net service revenue increased $15.0 million to $571.4 million compared to $556.4 million in 2023. Prior year included $15.0 million of net service revenue from our personal care business which was divested on March 31, 2023. ◦ Net incom ...

It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different ways to do both.Featuring daily updates of the Zacks Rank and Zacks Industry Rank, full access to the Zacks #1 Rank List, Equity Research reports, and Premium stock screens, the research service can help you become a smarter, more self-assured investor.Zacks Premium includes access to the Zacks Style Scores as we ...

A month has gone by since the last earnings report for Amedisys (AMED) . Shares have lost about 2.5% in that time frame, underperforming the S&P 500.Will the recent negative trend continue leading up to its next earnings release, or is Amedisys due for a breakout? Before we dive into how investors and analysts have reacted as of late, let's take a quick look at the most recent earnings report in order to get a better handle on the important drivers. Amedisys Q4 Earnings Miss Estimates, Margins RiseAmedisys, ...